Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Traditional Chinese Medicines (TCMs) on Patients With COVID-19 Infection: A Perspective, Open-labeled, Randomized, Controlled Trial

NCT04251871 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT04251871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Traditional Chinese Medicines (TCMs) on Patients With COVID-19 Infection: A Perspective, Open-labeled, Randomized, Controlled Trial
Lead sponsor
Beijing 302 Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 22, 2020
Completion date
January 22, 2021
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia caused by human coronavirus (disorder)